Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 383

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

High rates of 30-day mortality in patients with cirrhosis and COVID-19

Open access
Iavarone, Massimo, D'Ambrosio, Roberta, Soria, Alessandro, Triolo, Michela, Pugliese, Nicola, Del Poggio, Paolo, Perricone, Giovanni, Massironi, Sara, Spinetti, Angiola, Buscarini, Elisabetta, Viganò, Mauro, Carriero, Canio, Fagiuoli, Stefano, Aghemo, Alessio, Belli, Luca S., Lucà, Martina, Pedaci, Marianna, Rimondi, Alessandro, Rumi, Maria Grazia, Invernizzi, Pietro, Bonfanti, Paolo, Lampertico, Pietro·2020·Journal of Hepatology

Abstract

Background & Aims Coronavirus disease 2019 (COVID-19) poses a major health threat to healthy individuals and those with comorbidities, but its impact on patients with cirrhosis is currently unknown. Herein, we aimed to evaluate the impact of COVID-19 on the clinical outcome of patients with cirrhosis. Methods In this multicentre retrospective study, patients with cirrhosis and a confirmed severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection were enrolled between 1st and 31th March 2020. Clinical and biochemical data at diagnosis of COVID-19 and at the last outpatient visit were obtained through review of medical records. Results Fifty patients with cirrhosis and confirmed SARS-CoV-2 infection were enrolled (age 67 years, 70% men, 38% virus-related, 52% previously compensated cirrhosis). At diagnosis, 64% of patients presented fever, 42% shortness of breath/polypnea, 22% encephalopathy, 96% needed hospitalization or a prolonged stay if already in hospital. Respiratory support was necessary in 71%, 52% received antivirals, 80% heparin. Serum albumin significantly decreased, while bilirubin, creatinine and prothrombin time significantly increased at COVID-19 diagnosis compared to last available data. The proportion of patients with a model for end-stage liver disease (MELD) score ≥15 increased from 13% to 26% (p = 0.037), acute-on-chronic liver failure and de novo acute liver injury occurred in 14 (28%) and 10 patients, respectively. Seventeen patients died after a median of 10 (4–13) days from COVID-19 diagnosis, with a 30-day-mortality rate of 34%. The severity of lung and liver (according to CLIF-C, CLIF-OF and MELD scores) diseases independently predicted mortality. In patients with cirrhosis, mortality was significantly higher in those with COVID-19 than in those hospitalized for bacterial infections. Conclusion COVID-19 is associated with liver function deterioration and elevated mortality in patients with cirrhosis. Lay summary Coronavirus disease 2019 (COVID-19) poses a major health threat to healthy individuals and those with comorbidities. Herein, we assessed its impact on patients with cirrhosis. Infection with COVID-19 was associated with liver function deterioration and elevated mortality in patients with cirrhosis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jhep.2020.06.001

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 18 references

Cited by

See all 383

Metadata

Authors
Iavarone, M., D'Ambrosio, R., Soria, A., Triolo, M., Pugliese, N., Del Poggio, P., Perricone, G., Massironi, S., Spinetti, A., Buscarini, E., Viganò, M., Carriero, C., Fagiuoli, S., Aghemo, A., Belli, L. S., Lucà, M., Pedaci, M., Rimondi, A., Rumi, M. G., Invernizzi, P., Bonfanti, P., & Lampertico, P.
Venue
Journal of Hepatology
Publisher
Elsevier BV
Published
2020-11
Volume
73
Issue
5
Pages
1063-1071
ISSN
0168-8278 (ISSN-L)
OpenAlex
W3033189130
Cited by
383
References
18
FWCI
9.96
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: High rates of 30-day mortality in patients with cirrhosis and COVID-19. https://app.cochat.ai/papers/10.1016/j.jhep.2020.06.001
The paper
Iavarone, M., D'Ambrosio, R., Soria, A., Triolo, M., Pugliese, N., Del Poggio, P., Perricone, G., Massironi, S., Spinetti, A., Buscarini, E., Viganò, M., Carriero, C., Fagiuoli, S., Aghemo, A., Belli, L. S., Lucà, M., Pedaci, M., Rimondi, A., Rumi, M. G., . . . Lampertico, P. (2020). High rates of 30-day mortality in patients with cirrhosis and COVID-19. Journal of Hepatology. https://doi.org/10.1016/j.jhep.2020.06.001

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.